Table 1 Associations of PSGR expression with clinicopathological characteristics of PCa
| Â | PSGR | |
|---|---|---|
Mean ± SE | P | |
Age (years) | ||
  ≤ 61 (n = 72) | 130.90 ± 6.72 | 0.95 |
  > 61 (n = 78) | 131.40 ± 6.03 |  |
Tumor stage | ||
 T2a (n = 26) | 146.60 ± 11.90 | 0.33 |
 T2b (n = 39) | 127.61 ± 8.06 |  |
 T2c (n = 48) | 124.21 ± 7.74 |  |
 T3+ (n = 37) | 132.80 ± 7.52 |  |
Lymphovascular invasion | ||
 Present (n = 66) | 125.30 ± 6.51 | 0.19 |
 Absent (n = 84) | 136.72 ± 5.87 |  |
Extraprostatic extension | ||
 Present (n = 65) | 135.10 ± 6.99 | 0.83 |
 Absent (n = 85) | 132.90 ± 6.67 |  |